GGrantIndex
Sort

21,281 grants matching influenza

CENTERS OF EXCELLENCE FOR INFLUENZA RESEARCH AND SURVEILLANCE (CEIRS)

$8,340,973
Richard Webby · St. Jude Children'S Research Hospital · N01 · FY2018 · AI

Development of Human Anti-Influenza Monoclonal Antibodies for Treatment of Flu

$8,118,206
Jaap Goudsmit · Janessen Vaccines And Prevention, Bv · N01 · FY2012 · AI

The Infectious Diseases Clinical Research Program (IDCRP)

$8,100,000
National Institute Of Allergy And Infectious Diseases · Y01 · FY2013 · AI

Infectious Diseases Clinical Research Program

$8,100,000
National Institute Of Allergy And Infectious Diseases · Y01 · FY2011 · AI

The Infectious Diseases Clinical Research Program (IDCRP)

$8,100,000
National Institute Of Allergy And Infectious Diseases · Y01 · FY2012 · AI

Infectious Disease Clinical Research Program

$8,100,000
National Institute Of Allergy And Infectious Diseases · Y01 · FY2010 · AI

Systems Approach to Immunity and Inflammation

$8,033,507
Richard J Ulevitch · Scripps Research Institute, The · U19 · FY2016 · AI

Vaccine Immunology Program

$8,027,794
Adrian McDermott · National Institute Of Allergy And Infectious Diseases · ZIA · FY2021 · AI

CIVIC: University of Georgia Center for Influenza Vaccine Research in High Risk Populations

$8,000,000
Ted Ross · University Of Georgia · N01 · FY2025 · AI

CIVIC: University of Georgia Center for Influenza Vaccine Research in High Risk Populations

$8,000,000
Ted Ross · University Of Georgia · N01 · FY2019 · AI

Coordinating and Data Sharing Center - R&D of Vaccines and Antibodies for Pandemic Preparedness (ReVAMPP)

$7,994,888
Gregory D Sempowski · Research Triangle Institute · UG3 · FY2024 · AI

Collaborative Influenza Vaccine Innovation Centers (CIVICs)

$7,993,900
Tony Moody · Duke University · N01 · FY2025 · AI

Clinical Trails to Evaluate H5N1 Influenza Variant Vaccines

$7,985,002
Theresa Engel · Leidos Biomedical Research, Inc. · N01 · FY2024 · AI

Upgrading Institutional Capacity with a BSL-3 Facility for Multidisciplinary Biomedical Research

$7,947,160
Margaret Juliana McElrath · Fred Hutchinson Cancer Center · C06 · FY2025 · OD

COLLABORATIVE INFLUENZA VACCINE INNOVATION CENTER

$7,929,767
Tony Moody · Duke University · N01 · FY2019 · AI

Adjuvant Discovery for Vaccines against West Nile Virus and Influenza

$7,925,626
Dennis Carson · University Of California, San Diego · N01 · FY2014 · AI

COLLABORATIVE INFLUENZA VACCINE INNOVATION CENTER: CLINICAL CORE

$7,894,656
Emmanuel Walter · Duke University · N02 · FY2019 · AI

Development/production of universal influenza vaccines

$7,764,128
Richard Schwartz · National Institute Of Allergy And Infectious Diseases · ZIB · FY2016 · AI

High-throughput screening for novel adjuvant discovery for vaccines against influenza virus

$7,748,631
Nikolai Petrovsky · Vaxine Pty Ltd · N01 · FY2014 · AI

Vaccine Immunology Program

$7,744,191
Adrian McDermott · National Institute Of Allergy And Infectious Diseases · ZIA · FY2019 · AI

Antiviral Drug Discovery and Development Center - Overall

$7,623,789
Richard J. Whitley · University Of Alabama At Birmingham · U19 · FY2016 · AI

NIAID CENTERS OF EXCELLENCE FOR INFLUENZA RESEARCH AND RESPONSE: UNIVERSAL INFLUENZA RESEARCH

$7,604,783
Richard Webby · St. Jude Children'S Research Hospital · N01 · FY2023 · AI

Genomic Sequencing Center for Infectious Diseases

$7,599,319
William Charles Nierman · J. Craig Venter Institute, Inc. · N01 · FY2012 · AI

Vaccine Immunology Program

$7,577,903
Adrian McDermott · National Institute Of Allergy And Infectious Diseases · ZIA · FY2020 · AI

Biodefense/Emerging Infection Vaccine Studies

$7,568,442
Julie E. Ledgerwood · National Institute Of Allergy And Infectious Diseases · ZIA · FY2018 · AI